GAMIDA CELL LTD

YTD

ALL

Why Robinhood?

You can watch GMDAQ and buy or sell other stocks, ETFs, and their options commission-free!

About GMDAQ

Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases. Its product includes NiCord, a cell therapy based on NAM-expanded cord blood developed to improve and extend the life-saving benefits of hematopoietic stem cell transplant.

CEO

Joe Wiley, PhD, MBA

CEOJoe Wiley, PhD, MBA

Employees

—

Employees—

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1998

Founded1998

Employees

—

Employees—

GMDAQ Key Statistics

Market cap

2.62M

Market cap2.62M

Price-Earnings ratio

-0.03

Price-Earnings ratio-0.03

Dividend yield

—

Dividend yield—

Average volume

348.70K

Average volume348.70K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$2.51

52 Week high$2.51

52 Week low

$0.008

52 Week low$0.008